
H. Kataoka / Open Journal of Internal Medicine 2 (2012) 31-33 33
Figure 2. Standard 12-lead ECG of Case No. 2.
4. CONCLUSION
Based on the ECG findings, this case report suggested
that inherent predisposition to extreme enlargement and/
or hypertrophy may exist in atrial myocardium in juve-
nile HCM patients.
REFERENCES
[1] Maron, B.J., Spirito, P., Wesley, Y. and Arce, J. (1986)
Development and progression of left ventricular hyper-
trophy in children with hypertrophic cardiomyopathy:
Identification by two-dimensional echocardiography. The
New England Journal of Medicine 315, 610-614.
doi:10.1056/NEJM198609043151003
[2] Spirito, P. and Maron, B.J. (1989) Relation between extent
of left ventricular hypertrophy and age in hypertrophic
cardiomyopathy. Journal of the American College of
Cardiology, 13, 820-823.
doi:10.1016/0735-1097(89)90222-2
[3] Savage, D.D., Seides, S.F., Clark, C.E., Henry, W.L.,
Maron, B.J., Robinson, F.C. and Epstein, S.E. (1978)
Electrocardiographic findings in patients with obstructive
and nonobstructive hypertrophic cardiomyopathy. Circu-
lation, 58, 402-408.
[4] Morris, J.J. Jr., Estes, E.H. Jr., Whalen, R.E., Thompson,
H.K. Jr. and McIntosh, H.D. (1964) P-wave analysis in
valvular heart disease. Circulation, 29, 242-252.
[5] Maron, B.J., Henry, W.L., Clark, C.E., Redwood, D.R.,
Roberts, W.C. and Epstein, S.E. (1976) Asymmetric sep-
tal hypertrophy in childhood. Circulation, 53, 9-19.
[6] McKenna, W., Deanfield, J., Faruqui, A., England, D.,
Oakley, C. and Goodwin, J. (1981) Prognosis in hyper-
trophic cardiomyopathy: Role of age and clinical, elec-
trocardiographic and hemodynamic features. American
Journal of Cardiology, 47, 532-538.
doi:10.1016/0002-9149(81)90535-X
[7] Lazzeroni, E., Domenicucci, S., Ten Cate, F.J., Varacca,
A., Zoni, A., Francescon, P., Roelandt, J. and Botti, G.
(1988) Electrocardiographic abnormalities in hypertro-
phic cardimyopathy: Its relation to the extent of myocar-
dial hypertrophy. American Journal of Noninvasive Car-
diology, 2, 199-204.
[8] Pelliccia, A., Di Paolo, F.M., Corrado, D., Buccolieri, C.,
Quattrini, F.M., Pisicchio, C., Spataro, A, Biffi, A.,
Granata, M. and Maron, B.J. (2006) Evidence for efficacy
of the Italian national pre-participation screening pro-
gramme for identification of hypertrophic cardiomyopa-
thy in competitive athletes. European Heart Journal, 27,
2196-2200. doi:10.1093/eurheartj/ehl137
[9] Olivotto, I., Cecchi, F., Casey, S.A., Dolara, A., Traverse,
J.H. and Maron, B.J. (2001) Impact of atrial fibrillation
on the clinical course of hypertrophic cardiomyopathy.
Circulation, 104, 2517-2524. doi:10.1161/hc4601.097997
[10] Köse, S., Aytemir, K., Sade, E., Can, I., Özer, N.,
Amasyali, B., Aksöyek, S., Övünç, K., Özmen, F., Atalar,
E., Işik, E., Kes, S., Demirtaş, E. and Oto, A. (2003) De-
tection of patients with hypertrophic cardimyopathy at
risk for paroxysmal atrial fibrillation during sinus rhythm
by P-wave dispersion. Clinical Cardiology, 26, 431-434.
doi:10.1002/clc.4960260910
Copyright © 2012 SciRes. OPEN ACCESS